These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

956 related items for PubMed ID: 26796596

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD.
    Addict Sci Clin Pract; 2019 Oct 01; 14(1):37. PubMed ID: 31570100
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD, Maradiaga J, Weiss L, Sanchez J, Starrels JL, Cunningham CO.
    Addict Sci Clin Pract; 2015 Jan 16; 10(1):2. PubMed ID: 25592182
    [Abstract] [Full Text] [Related]

  • 6. A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients.
    Kelly SM, Brown BS, Katz EC, O'Grady KE, Mitchell SG, King S, Schwartz RP.
    Am J Drug Alcohol Abuse; 2012 May 16; 38(3):233-8. PubMed ID: 22242643
    [Abstract] [Full Text] [Related]

  • 7. Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.
    Bishop B, Gilmour J, Deering D.
    Int J Ment Health Nurs; 2019 Feb 16; 28(1):226-236. PubMed ID: 30019812
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Consumer attitudes about opioid addiction treatment: a focus group study in New York City.
    Sohler NL, Weiss L, Egan JE, López CM, Favaro J, Cordero R, Cunningham CO.
    J Opioid Manag; 2013 Feb 16; 9(2):111-9. PubMed ID: 23709320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. "I wanted something that was more flexible": A qualitative study of patient preferences on choosing buprenorphine over methadone in a large, safety-net hospital opioid treatment program.
    Checkley L, Steiger S, Knight KR.
    Subst Abus; 2022 Feb 16; 43(1):767-773. PubMed ID: 35112998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients.
    Notley C, Blyth A, Maskrey V, Pinto H, Holland R.
    Subst Abus; 2015 Feb 16; 36(2):232-9. PubMed ID: 25127184
    [Abstract] [Full Text] [Related]

  • 14. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ.
    Pharmacotherapy; 2017 Jul 16; 37(7):824-839. PubMed ID: 28543191
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
    Winstock AR, Lintzeris N, Lea T.
    Int J Drug Policy; 2011 Jan 16; 22(1):77-81. PubMed ID: 20956077
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.